Predictors of Participation in Prenatal Substance Use Assessment, Counseling, and Treatment Among Pregnant Individuals in Prenatal Settings Who Use Cannabis
Authors:
- Gwen T. PhD LaphamGLGwen T. PhD Lapham
- Felicia W. ChiFCFelicia W. Chi
- Kelly C. Young-WolffKelly C. Young-Wolff
- Deborah AnsleyDADeborah Ansley
- Carley Mft CastellanosCCCarley Mft Castellanos
- Monique B. DoesMDMonique B. Does
- Asma H. AsyyedAAAsma H. Asyyed
- Allison Msc EttengerAEAllison Msc Ettenger
- Cynthia I. CampbellCCCynthia I. Campbell
Open Access
- 15 November 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 19 (2) , 179-186
Abstract
Objectives: Assessment and counseling are recommended for individuals with prenatal cannabis use. We examined characteristics that predict prenatal substance use assessment and counseling among individuals who screened positive for prenatal cannabis use in prenatal settings. Methods: Electronic health record data from Kaiser Permanente Northern California’s Early Start perinatal substance use screening, assessment, and counseling program was used to identify individuals with ≥1 pregnancies positive for prenatal cannabis use. Outcomes included completion of a substance use assessment and among those assessed, attendance in Early Start counseling only or Addiction Medicine Recovery Services (AMRS) treatment. Predictors included demographics and past-year psychiatric and substance use disorder diagnoses evaluated with GEE multinomial logistic regression. Results: The sample included 17,782 individuals with 20,398 pregnancies positive for cannabis use (1/2011–12/2021). Most pregnancies (80.3%) had an assessment. Individuals with Medicaid, anxiety, depression and tobacco use disorders, compared to those without, had higher odds and those with greater parity, older age (≥35) and in later trimesters, had lower odds of assessment. Among 64% (n = 10,469) pregnancies needing intervention based on assessment, most (88%) attended Early Start counseling only or AMRS (with or without Early Start). Greater parity and later trimester assessment was associated with lower odds, while Medicaid was associated with higher odds of Early Start counseling. Nearly all diagnosed psychiatric and substance use disorders were associated with higher odds of AMRS treatment. Conclusions: A comprehensive prenatal substance use program engaged most pregnant individuals with prenatal cannabis use in substance use assessment and counseling. Opportunities to improve care gaps remain.Keywords
This publication has 35 references indexed in Scilit:
- Treatment outcomes among pregnant women with cannabis use disorderAddictive Behaviors, 2023
- Birth Outcomes of Neonates Exposed to Marijuana in UteroJAMA Network Open, 2022
- Associations Between Prenatal Cannabis Exposure and Childhood OutcomesJAMA Psychiatry, 2020
- Correlates of Pregnant Women’s Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal CareMaternal and Child Health Journal, 2020
- Cannabis use among women of reproductive age in the United States: 2002–2017Addictive Behaviors, 2019
- Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016JAMA, 2017
- Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidityAmerican Journal of Obstetrics and Gynecology, 2017
- The Prevalence and Impact of Substance Use Disorder and Treatment on Maternal Obstetric Experiences and Birth Outcomes Among Singleton Deliveries in MassachusettsMaternal and Child Health Journal, 2016
- Treatment of Cannabis Use Disorder: Current Science and Future OutlookPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- The Development of a Standardized Neighborhood Deprivation IndexJournal of Urban Health, 2006